ALS Drug Gets Support of FDA Advisers in Rare Second Review

A closely watched experimental drug for Lou Gehrig’s disease got an unusual second look from U.S. regulators on Wednesday, following intense pressure to...

Related Keywords

China ,San Diego ,California ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Massachusetts ,Chinese ,Amylyx Pharma ,Lou Gehrig ,Justin Klee ,Caleb Alexander ,Tristan Massie ,Billy Dunn ,Johns Hopkins University ,Indiana University School Of Medicine ,National Institutes Of Health ,Drug Administration ,Liana Apostolova ,Indiana University ,Dean Follmann ,National Institutes ,Greg Canter ,Fda ,Lou Gehrigs Disease ,